PCR corrected ACPR on Day 28 Day 28 [clinicaltrials_resource:9f3ba7ea287257edea4ac93f61ade634]

PCR corrected ACPR on Day 28 Day 28 [clinicaltrials_resource:9f3ba7ea287257edea4ac93f61ade634]

60mg pyronaridine and 20mg artesunate fixed dose combination granule formulation for 3 consecutive days
clinicaltrials resource [clinicaltrials_vocabulary:Resource]
Secondary outcome [clinicaltrials_vocabulary:secondary-outcome]
http://bio2rdf.org/clinicaltrials_resource:9f3ba7ea287257edea4ac93f61ade634
Pyronaridine Artesunate 3:1 Granule Formulation vs. Coartem© Crushed Tablets in P. Falciparum Malaria Pediatric Patients [clinicaltrials:NCT00541385]
clinicaltrials_vocabulary:secondary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:secondary-outcome]

PCR corrected ACPR on Day 28 Day 28 [clinicaltrials_resource:9f3ba7ea287257edea4ac93f61ade634]

60mg pyronaridine and 20mg artesunate fixed dose combination granule formulation for 3 consecutive days
clinicaltrials resource [clinicaltrials_vocabulary:Resource]
Secondary outcome [clinicaltrials_vocabulary:secondary-outcome]
http://bio2rdf.org/clinicaltrials_resource:9f3ba7ea287257edea4ac93f61ade634
Bio2RDF identifier
9f3ba7ea287257edea4ac93f61ade634
Bio2RDF namespace
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:9f3ba7ea287257edea4ac93f61ade634
measure [clinicaltrials_vocabulary:measure]
PCR corrected ACPR on Day 28
time frame [clinicaltrials_vocabulary:time-frame]
description
60mg pyronaridine and 20mg art ...... ulation for 3 consecutive days
identifier
clinicaltrials_resource:9f3ba7ea287257edea4ac93f61ade634
title
PCR corrected ACPR on Day 28 Day 28
@en
inDataset
type
label
PCR corrected ACPR on Day 28 D ...... ba7ea287257edea4ac93f61ade634]
@en